litlas
Log inCreate account

Peter Marynen

Active 1981–2016

91
Papers
21,606
Citations
83
h-index
90
i10-index

Citations

Citations per year for Peter Marynen1982: 2 citations1984: 1 citations1985: 2 citations1986: 2 citations1987: 1 citations1988: 4 citations1989: 5 citations1990: 12 citations1991: 18 citations1992: 36 citations1993: 25 citations1994: 36 citations1995: 26 citations1996: 39 citations1997: 50 citations1998: 63 citations1999: 98 citations2000: 140 citations2001: 166 citations2002: 114 citations2003: 148 citations2004: 149 citations2005: 256 citations2006: 281 citations2007: 318 citations2008: 344 citations2009: 328 citations2010: 326 citations2011: 292 citations2012: 294 citations2013: 231 citations2014: 215 citations2015: 204 citations2016: 177 citations2017: 175 citations2018: 161 citations2019: 364 citations2020: 353 citations2021: 352 citations2022: 215 citations2023: 162 citations2024: 221 citations2025: 78 citations1983: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,685 citing papers, 28.6% of this breakdownUnited Kingdom: 851 citing papers, 9% of this breakdownGermany: 688 citing papers, 7.3% of this breakdownFrance: 503 citing papers, 5.3% of this breakdownBelgium: 443 citing papers, 4.7% of this breakdownChina: 433 citing papers, 4.6% of this breakdownItaly: 421 citing papers, 4.5% of this breakdownCanada: 330 citing papers, 3.5% of this breakdownNetherlands: 307 citing papers, 3.3% of this breakdownJapan: 261 citing papers, 2.8% of this breakdownSwitzerland: 243 citing papers, 2.6% of this breakdownAustralia: 227 citing papers, 2.4% of this breakdown
0%28.6%Other 21.4%

Institutions

Fields

  • Medicine50.8%
  • Biochemistry, Genetics and Molecular Biology42.5%
  • Immunology and Microbiology3.1%
  • Neuroscience1.2%
  • Computer Science0.8%
  • Agricultural and Biological Sciences0.7%
  • Other0.9%

Topics

  • Myeloproliferative Neoplasms: Diagnosis and Treatment4.8%
  • Chronic Myeloid Leukemia Treatments3.7%
  • Acute Myeloid Leukemia Research3.6%
  • Cancer Genomics and Diagnostics3.2%
  • Eosinophilic Disorders and Syndromes3.1%
  • Lymphoma Diagnosis and Treatment2.3%
  • Other79.3%

Coauthors

All papers

Open in search
  1. Allele-specific copy number analysis of tumors

    Authors: Peter Van Loo, Silje Nord, Ole Christian Lingjærde, Hege G. Russnes, Inga Hansine Rye, Wei Sun, Victor Weigman, Peter Marynen, Anders Zetterberg, Bjørn Naume, Charles M. Perou, Anne‐Lise Børresen‐Dale, Vessela N. Kristensen - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 1,331

  2. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

    Authors: Ross L. Levine, Martha Wadleigh, Jan Cools, Benjamin L. Ebert, Gerlinde Wernig, Brian J.P. Huntly, Titus J. Boggon, Iwona Włodarska, Jennifer Clark, Sandra Moore, Jennifer Adelsperger, Sumin Koo, Jeffrey C. Lee, Stacey Gabriel, Thomas Mercher, Alan D. D’Andrea, Stefan Fröhling, Konstanze Döhner, Peter Marynen, Peter Vandenberghe, Ruben A. Mesa, Ayalew Tefferi, James D. Griffin, Michael J. Eck, William R. Sellers, Matthew Meyerson, Todd R. Golub, Stephanie J. Lee, D. Gary Gilliland - Cancer Cell 2005 cited by 2,991

  3. Duplication of the MECP2 Region Is a Frequent Cause of Severe Mental Retardation and Progressive Neurological Symptoms in Males

    Authors: Hilde Van Esch, Marijke Bauters, Jaakko Ignatius, Mieke Jansen, Martine Raynaud, Karen Hollanders, Dorien Lugtenberg, Thierry Bienvenu, Lars Riff Jensen, Jozef Gécz, Claude Moraine, Peter Marynen, Jean‐Pierre Fryns, Guy Froyen - The American Journal of Human Genetics 2005 cited by 627

  4. T cell antigen receptor stimulation induces MALT1 paracaspase–mediated cleavage of the NF-κB inhibitor A20

    Authors: Beatrice Coornaert, Mathijs Baens, Karen Heyninck, Tine Bekaert, Mira Haegman, Jens Staal, Lijun Sun, Zhijian J. Chen, Peter Marynen, Rudi Beyaert - Nature Immunology 2008 cited by 429

  5. A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome

    Authors: Jan Cools, Daniel J. DeAngelo, Jason Gotlib, Elizabeth H. Stover, Robert D. Legare, Jörge E. Cortes, Jeffrey L. Kutok, Jennifer Clark, Ilene Galinsky, James D. Griffin, Nicholas C.P. Cross, Ayalew Tefferi, James Malone, Rafeul Alam, Stanley L. Schrier, Janet Schmid, Michal G. Rose, Peter Vandenberghe, Gregor Verhoef, Marc Boogaerts, Iwona Włodarska, Hagop M. Kantarjian, Peter Marynen, Steven Coutré, Richard M. Stone, D. Gary Gilliland - New England Journal of Medicine 2003 cited by 1,698

  6. Gene prioritization through genomic data fusion

    Authors: Stein Aerts, Diether Lambrechts, Sunit Maity, Peter Van Loo, Bert Coessens, Frederik De Smet, Léon-Charles Tranchevent, Bart De Moor, Peter Marynen, Bassem A. Hassan, Peter Carmeliet, Yves Moreau - Nature Biotechnology 2006 cited by 907

  7. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1–like phenotype

    Authors: Hilde Brems, Magdalena Chmara, Mourad Sahbatou, Ellen Denayer, Koji Taniguchi, Reiko Kato, Riet Somers, Ludwine Messiaen, Sofie De Schepper, Jean‐Pierre Fryns, Jan Cools, Peter Marynen, Gilles Thomas, Akihiko Yoshimura, Eric Legius - Nature Genetics 2007 cited by 473

  8. A20 Negatively Regulates T Cell Receptor Signaling to NF-κB by Cleaving Malt1 Ubiquitin Chains

    Authors: Michael Düwel, Verena Welteke, Andrea Oeckinghaus, Mathijs Baens, Bernhard Kloo, Uta Ferch, Bryant G. Darnay, Jürgen Ruland, Peter Marynen, Daniel Krappmann - The Journal of Immunology 2009 cited by 234

  9. Identification of Intellectual Disability Genes in Female Patients with a Skewed X-Inactivation Pattern

    Authors: Nathalie Fieremans, Hilde Van Esch, Maureen Holvoet, Gert Van Goethem, Koenraad Devriendt, Mónica Rosello, Sonia Mayo, Francisco Martı́nez, Shalini N. Jhangiani, Donna M. Muzny, Richard A. Gibbs, James R. Lupski, Joris Vermeesch, Peter Marynen, Guy Froyen - Human Mutation 2016 cited by 126

  10. TP53 mutations are frequent in malignant NFI tumors

    Authors: Eric Legius, Herman A. Dierick, Rina Wu, Bryan K. Hall, Peter Marynen, Jean‐Jacques Cassiman, Thomas W. Glover - Genes Chromosomes and Cancer 1994 cited by 196

  11. The Dark Side of EGFP: Defective Polyubiquitination

    Authors: Mathijs Baens, Heidi Noels, Vicky Broeckx, Sofie Hagens, Sabine Fevery, An Billiau, Hugo Vankelecom, Peter Marynen - PLoS ONE 2006 cited by 150

  12. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

    Authors: Carlos Graux, Jan Cools, Cindy Melotte, Hilmar Quentmeier, Adolfo A. Ferrando, Ross L. Levine, Joris Vermeesch, Michel Stul, Binita Dutta, Nancy Boeckx, André Bosly, Pierre Heimann, Anne Uyttebroeck, Nicole Mentens, R. Somers, Roderick A.F. MacLeod, Hans G. Drexler, A. Thomas Look, D. Gary Gilliland, Lucienne Michaux, Peter Vandenberghe, Iwona Włodarska, Peter Marynen, Anne Hagemeijer - Nature Genetics 2004 cited by 422

  13. Efficacy of the Kinase Inhibitor SU11248 against Gastrointestinal Stromal Tumor Mutants Refractory to Imatinib Mesylate

    Authors: Hans Prenen, Jan Cools, Nicole Mentens, Cedric Folens, Raf Sciot, Patrick Schöffski, A. van Oosterom, Peter Marynen, Maria Dêbiec‐Rychter - Clinical Cancer Research 2006 cited by 275

  14. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation

    Authors: Marina Bousquet, Cathy Quelen, Roberto Rosati, Véronique Mansat‐De Mas, Roberta La Starza, Christian Bastard, Éric Lippert, Pascaline Talmant, Mårina Lafage‐Pochitaloff, Dominique Leroux, Carine Gervais, F Viguié, Jean‐Luc Laï, Christine Terré, Berna Beverlo, C. Sambani, Anne Hagemeijer, Peter Marynen, Georges Delsol, Nicole Dastugue, Cristina Mecucci, Pierre Brousset - The Journal of Experimental Medicine 2008 cited by 248

  15. ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma

    Authors: Pascale De Paepe, Mathijs Baens, J. Han van Krieken, Bruno Verhasselt, Michel Stul, Annet Simons, Bruce Poppe, Geneviève Laureys, Paul Brons, Peter Vandenberghe, Frank Speleman, Marleen Praet, Chris De Wolf‐Peeters, Peter Marynen, Iwona Włodarska - Blood 2003 cited by 191

  16. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large‐cell lymphoma and inflammatory myofibroblastic tumor

    Authors: Jan Cools, Iwona Włodarska, Riet Somers, Nicole Mentens, Florence Pédeutour, Brigitte Maes, Christiane De Wolf‐Peeters, Patrick Pauwels, Anne Hagemeijer, Peter Marynen - Genes Chromosomes and Cancer 2002 cited by 287

  17. Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells.

    Authors: Stefan Joos, M Küpper, S. Öhl, Frederike von Bonin, Gunhild Mechtersheimer, Martin Bentz, Peter Marynen, Peter Mӧller, Michael Pfreundschuh, Lorenz Trümper, Peter Lichter - 2000 cited by 278

  18. Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia

    Authors: Idoya Lahortiga, Kim De Keersmaecker, Pieter Van Vlierberghe, Carlos Graux, Barbara Cauwelier, Frédéric Lambert, Nicole Mentens, H. Berna Beverloo, Rob Pieters, Frank Speleman, María D. Odero, Marijke Bauters, Guy Froyen, Peter Marynen, Peter Vandenberghe, Iwona Włodarska, Jules P.P. Meijerink, Jan Cools - Nature Genetics 2007 cited by 276

  19. Submicroscopic Duplications of the Hydroxysteroid Dehydrogenase HSD17B10 and the E3 Ubiquitin Ligase HUWE1 Are Associated with Mental Retardation

    Authors: Guy Froyen, Mark Corbett, Joke Vandewalle, Irma Järvelä, Owen Lawrence, Cliff Meldrum, Marijke Bauters, Karen Govaerts, Lucianne Vandeleur, Hilde Van Esch, Jamel Chelly, Damien Sanlaville, Hans van Bokhoven, Hans‐Hilger Ropers, Frédéric Laumonnier, Enzo Ranieri, Charles E. Schwartz, Fatima Abidi, Patrick Tarpey, P. Andrew Futreal, Annabel Whibley, F. Lucy Raymond, Michael R. Stratton, Jean‐Pierre Fryns, Rodney J. Scott, Maarit Peippo, Marjatta Sipponen, M. W. Partington, David Mowat, Michael Field, Anna Hackett, Peter Marynen, Gillian Turner, Jozef Gécz - The American Journal of Human Genetics 2008 cited by 220

  20. Prediction of Resistance to Small Molecule FLT3 Inhibitors

    Authors: Jan Cools, Nicole Mentens, Pascal Furet, Doriano Fabbro, Jennifer Clark, James D. Griffin, Peter Marynen, D. Gary Gilliland - Cancer Research 2004 cited by 174

  21. ALK‐ATIC fusion in urinary bladder inflammatory myofibroblastic tumor

    Authors: Maria Dêbiec‐Rychter, Peter Marynen, Anne Hagemeijer, Patrick Pauwels - Genes Chromosomes and Cancer 2003 cited by 137

  22. Glypican-6, a New Member of the Glypican Family of Cell Surface Heparan Sulfate Proteoglycans

    Authors: Mark Veugelers, Bart De Cat, Helga Ceulemans, Anne-Marie Bruystens, Christien Coomans, Joachim Dürr, Joris Vermeesch, Peter Marynen, Guido David - Journal of Biological Chemistry 1999 cited by 134

  23. FIP1L1-PDGFRα D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRα T674I eosinophilic leukemia with single agent sorafenib

    Authors: Els Lierman, Lucienne Michaux, E Beullens, P. Pierre, Peter Marynen, Jan Cools, Peter Vandenberghe - Leukemia 2009 cited by 127

  24. A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias

    Authors: Frank Speleman, Barbara Cauwelier, Nicole Dastugue, Jan Cools, Bruno Verhasselt, Bruce Poppe, Nadine Van Roy, Jo Vandesompele, Carlos Graux, Anne Uyttebroeck, M. Boogaerts, Barbara De Moerloose, Yves Benoît, Dominik Selleslag, Johan Billiet, A Robert, Françoise Huguet, Peter Vandenberghe, Anne De Paepe, Peter Marynen, A Hagemeijer - Leukemia 2005 cited by 118